International Stem Cell Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 5/30/2017
Contact Info
  • 5950 Priestly Drive
  • Carlsbad, CA 92008

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001355790
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2005
Employees 43 a/o May 30, 2017
Company Officers/Contacts
Andrey Semechkin CEO
Charles Casamento Administrator
Mahnaz Ebrahimi CFO
Sophia Garnette VP, Legal, VP, Ops.
Russell Kern CSO, EVP
Investor Relations IR
Company Directors
Donald Wright Co-Chairman
Andrey Semechkin Co-Chairman
Charles Casamento
Paul V. Maier
Service Providers
Accounting/Auditing Firm
Mayer Hoffman McCann, P.C. (CA)
2301 Dupont Drive
Suite 200
Irvine, CA, 92612
United States
Securities Counsel
4365 Executive Drive
Suite 1100
San Diego, CA, 92101-4297
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=BTHC III, Inc. until 1-07
ISCO Security Details
Share Structure
Market Value1 $4,605,641 a/o Jun 23, 2017
Authorized Shares 120,000,000 a/o Mar 31, 2017
Outstanding Shares 4,004,905 a/o May 12, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders of Record 9,100 a/o Mar 30, 2016
Short Selling Data
Short Interest 6,637 (13.45%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security